Amprius offers a high-risk, high-upside silicon-anode battery scale-up story: world-class energy density is proven, but shareholder returns depend on manufacturing execution, margin recovery and NDAA-compliant defense supply chains.
Amprius Technologies Inc is an advanced commercial-stage developer and manufacturer of disruptive, high-energy-density silicon-anode lithium-ion batteries tailored for next-generation mobility and mission-critical applications.[1, 2] The company operates a corporate headquarters and a research and development pilot manufacturing line in Fremont, California, while pursuing an outsourced, asset-light contract manufacturing model to scale production capacities globally.[3, 4]
The company generates revenue primarily through the sale of high-performance cylindrical and pouch battery cells and integrated battery packs to defense, aerospace, and commercial mobility clients.[3, 4, 5] Historically, Amprius has maintained a highly concentrated customer base, with a substantial share of export shipments targeted at the European and Asian markets.[5, 6] Over the past fiscal year, geographic diversification has expanded, with North American sales rising to represent approximately 20% of the total revenue mix as of the first quarter of 2026, while EMEA shipments—including a substantial volume of defense-related cells delivered to Ukraine—remain major operational drivers.[5, 7]
At the core of the company's product portfolio are its proprietary silicon anode structures, marketed under two principal platforms [2]:
* SiCore: Introduced commercially in early 2024, the SiCore platform delivers balanced energy and power density.[8, 9] It is engineered to run on standard, unmodified lithium-ion manufacturing lines, bypassing the requirement for bespoke tooling and enabling rapid scaling through external contract manufacturing partners.[8, 10]
* SiMaxx: Representing the company's pinnacle technology, the SiMaxx platform utilizes a proprietary 100% silicon nanowire structure to achieve specific energy densities of 435 to 500 Wh/kg.[2, 8] However, due to high manufacturing complexity and significant fixed overhead costs on its pilot line, the company is actively phasing out SiMaxx production in Fremont to focus commercial scaling efforts on the higher-margin, highly scalable SiCore platform.[7, 11]
The primary customer types for Amprius are aerospace defense contractors, unmanned aerial systems (UAS) manufacturers, high-altitude pseudo-satellite (HAPS) developers, electric vertical takeoff and landing (eVTOL) pioneers, and premium light electric vehicle (LEV) manufacturers.[12, 13] Core institutional customers include Airbus, AeroVironment, Teledyne FLIR, and L3Harris Technologies.[4, 13]
These sophisticated buyers choose Amprius over conventional battery manufacturers because traditional graphite-anode cells possess a theoretical capacity limit of 355 mAh/g, whereas Amprius’ silicon anodes deliver up to 3,400 mAh/g.[2] This technological leap translates to up to a 100% improvement in runtime, structural weight reduction, payload expansion, extreme low-temperature performance (-30°C to 55°C), and ultra-fast charging capability, allowing cells to reach an 80% state of charge in under six minutes.[2, 13, 14]
Amprius is transitioning from a technology validation phase into a commercial scaling era, driven by a capital-light operational model.[3, 15] The main revenue drivers center on expanding relationships with military drone manufacturers and breaking into the high-volume consumer ground mobility segment.[1, 16]
To support this growth, the company terminated its 15-year facility lease in Brighton, Colorado, in January 2026 for a one-time termination fee of $20.0 million.[17, 18] While this decision nixed a planned $50 million Department of Energy grant, it eliminated over $110 million in long-term lease liabilities, allowing management to redeploy cash into high-volume manufacturing partnerships.[17, 18]
Key growth initiatives include scaling production through a tier-one South Korean battery manufacturer [19, 20] and securing a domestic contract with California-based Nanotech Energy to establish a secure, National Defense Authorization Act (NDAA) compliant production pathway for U.S. military clients.[4, 18] Additionally, a recent $21.0 million purchase order for SiCore cylindrical cells from a Chinese light electric vehicle customer demonstrates the successful expansion of Amprius’ technology into ground-based urban mobility.[1, 16]
The core technical differentiation between Amprius' two battery architectures dictates their distinct manufacturing economics and target applications:
| Product Platform | Specific Energy Density | Volumetric Density | Discharge C-Rate | Cycle Life (100% DoD) | Manufacturing Method | Primary End Markets |
|---|---|---|---|---|---|---|
| SiCore | ~370 Wh/kg [8] | ~1,000 Wh/L [12] | 10C (Uncooled) to 15C (Cooled) [8] | ~300 Cycles [8] | Standard Li-ion manufacturing lines with recipe tweaks [10] | eVTOL, drones, LEVs, industrial robotics [8] |
| SiMaxx | 435–500 Wh/kg [8] | 1,150–1,300 Wh/L [20] | ~2C [8] | 500–1,000 Cycles [8] | Highly complex, bespoke nanowire growth processes [8] | High-end aerospace, HAPS, military wearables [8] |
The physical mechanism of SiMaxx utilizes pure, 100% silicon nanowires grown directly on the substrate via chemical vapor deposition.[8, 21] This design provides open spaces within the electrode structure to accommodate silicon’s characteristic 300% volume expansion during lithiation without fracturing the cell, maintaining structural integrity over hundreds of cycles.[10]
In contrast, SiCore employs a proprietary silicon-graphite composite anode structure that controls volume changes through advanced binder systems and electrolyte chemistry, enabling the material to be slurry-coated using standard commercial mixers, coaters, calendars, and slitters.[10] This compatibility allows Amprius to leverage external gigawatt-hour (GWh) scale factories, drastically reducing capital expenditure requirements.[8, 10, 20]
Amprius possess a multi-layered economic moat that protects its pricing power and long-term positioning:
* High Switching Costs: In the aerospace and defense sectors, battery cells must undergo multi-year qualification programs, environmental stress testing, and safety certifications.[6, 10, 21] Once Amprius' high-density cells are structurally and thermally integrated into a military drone (such as AeroVironment's P550 UAS) or a high-altitude pseudo-satellite (such as the Airbus Zephyr S), the technical, regulatory, and financial friction required for a customer to switch to a competitor is exceptionally high.[11, 13, 21]
* Intellectual Property Protection: The company’s technology is protected by a global portfolio of 86 issued and pending patents as of December 31, 2025.[9] This IP covers the physical architecture of the silicon nanowires, lattice expansion-tolerant designs, and specialized electrolyte formulations designed to prevent gas generation and impedance build-up at the anode-electrolyte interface.[10, 21]
* First-Mover and Flight Heritage: Unlike many next-generation battery developers that remain in pre-commercial laboratory testing, Amprius has years of commercial flight heritage.[21] This operational track record establishes a trusted brand in high-stakes aerospace markets where battery reliability is critical.[13, 21]
The addressable market for Amprius' high-performance batteries is expanding rapidly across multiple transportation and defense vectors. The global aviation battery market, spanning unmanned aerial systems, high-altitude pseudo-satellites, and air transportation (eVTOL), is projected to grow to a $50 billion total addressable market.[13]
The introduction of the SiCore platform opens up the high-volume light electric vehicle (LEV) sector, which is driven by urban electrification and urban air mobility trends.[1, 12] Furthermore, emerging verticals such as humanoid robotics, tactical military wearable equipment, and advanced medical devices are projected to add tens of billions in incremental long-term addressable market opportunity.[12, 22]
The advanced battery landscape is characterized by intense research and development, with Amprius positioned as a premium, density-first provider. Key competitors can be categorized into direct silicon-anode developers, solid-state innovators, and legacy battery conglomerates:
* Sila Nanotechnologies: Carrying a valuation exceeding $3 billion, Sila focuses on scalable silicon-graphite composite anodes and has deep manufacturing ties with Mercedes-Benz.[21] Sila prioritizes mass automotive cost-structures and standard form factors, whereas Amprius’ SiMaxx platform maintains an energy density lead of approximately 20% to 30%, giving Amprius a performance advantage in weight-sensitive aerospace applications.[8, 21]
* Enovix Corporation: Enovix utilizes a unique 3D mechanical cell architecture to restrain silicon expansion under high pressure, targeting the consumer electronics and automotive electric vehicle markets.[21, 23] While Enovix has achieved high energy densities, its proprietary assembly process faces manufacturing throughput constraints, contrasting with the easier scalability of Amprius' SiCore platform on standard commercial lines.[8, 21]
* Solid-State Disruptors: Companies such as QuantumScape, Solid Power, and Factorial Energy represent the "solid-state promise".[21] While solid-state technology could eventually deliver superior safety and volumetric density, these competitors remain largely pre-commercial.[21] Amprius holds a strategic advantage by actively shipping commercially validated liquid-electrolyte cells today.[21]
* Global Battery Titans: Mega-manufacturers such as CATL, LG Energy Solution, and Panasonic control over 60% of the lithium-ion market.[21] These giants compete primarily on scale, cost-minimization, and high-volume automotive contracts, typically trailing Amprius' specific energy density by up to 50%.[21] Amprius avoids direct competition with these giants by focusing on premium niches where payload limits and specific energy (Wh/kg) are valued above simple cost-per-kilowatt-hour.[21, 22, 24]
Amprius announced its first-quarter 2026 financial results on May 6, 2026, with the corresponding earnings webcast held on May 7, 2026.[1, 25]
| Income Statement Line Item (Q1) | Q1 2026 (Actual) | Q1 2025 (Actual) | YoY Change (%) | vs. Wall Street Expectations |
|---|---|---|---|---|
| Revenue | $28.54M | $11.28M | +153.0% [1] | Beat (Est: $25.3M–$25.7M) [11, 26] |
| Cost of Revenue | $22.80M | $13.65M | +67.0% [29] | Reflects scaling third-party production [5] |
| Gross Profit (Loss) | $5.74M | ($2.36M) | +343.2% [29] | Improved scale and product mix [5] |
| Gross Margin (%) | 20.0% | (21.0%) | +4,100 bps [1] | Sequential decrease from Q4 2025 (24%) [11] |
| R&D Expense | $3.80M | $2.00M | +90.0% [29] | Driven by continuous chemistry upgrades [5] |
| SG&A Expense | $8.63M | $5.31M | +62.5% [29] | Reflects administrative expansion [5] |
| GAAP Net Loss | ($5.05M) | ($9.37M) | +46.1% [1] | Missed (Est: -$0.02 to -$0.03) [11, 26] |
| Adjusted EBITDA | ($1.80M) | ($5.20M) | +65.4% [1] | Narrowing operational losses [5] |
As of March 31, 2026, Amprius maintained a debt-free balance sheet with $62.35 million in cash and cash equivalents, down from $90.47 million as of December 31, 2025.[7, 29] This cash decrease was driven by a high quarterly operating cash outflow of $37.30 million, which was impacted by the one-time $20.0 million cash payment to terminate the Brighton, Colorado facility lease.[5]
Accounts receivable stood at $35.26 million, reflecting growth in bill-and-hold arrangements, which accounted for $5.80 million in Q1 2026 compared to $5.40 million in Q1 2025.[5, 29] Liquidity was bolstered in April 2026 with the collection of over $6.50 million in accounts receivable, bringing the company's cash position to $71.20 million as of May 1, 2026.[7, 30]
Following the strong top-line momentum in Q1 2026, management raised its full-year 2026 revenue guidance to at least $130.0 million, up from the prior outlook of at least $125.0 million, representing year-over-year growth of at least 78% relative to FY 2025’s $73.0 million.[1, 17] Management reiterated all other full-year 2026 outlook targets, which are detailed in the following table:
| Full-Year 2026 Guidance Metric | Target Value (Reiterated) | Underlying Assumptions |
|---|---|---|
| Total Revenue | $\ge$ $130.0M (Raised from $125M) [1] | Driven by additional Q1 demand and LEV scaling [1] |
| Net Loss | < $8.0M [1] | Assumes fading legacy overheads in H2 2026 [11, 26] |
| Net Loss Per Share | < $0.06 [1] | Assumes 132.0M–136.9M weighted average shares [1, 17] |
| Adjusted EBITDA | $\ge$ $4.0M [1] | Reflects positive operating leverage [31] |
| Capital Expenditure | < $10.0M [1] | Guided by capital-efficient outsourced model [7] |
| Depreciation & Amortization | $4.7M [17] | Reflects Fremont pilot line assets [17] |
| Stock-Based Compensation | $8.3M [17] | Key driver of non-cash expense [17] |
On the earnings call, CEO Tom Stepien emphasized that Q1 results validate the market acceptance of the SiCore platform.[1] He pointed to the recent $21.0 million LEV order as a key catalyst demonstrating that silicon-anode performance can scale cost-effectively in non-aerospace markets.[1, 16]
CFO Ricardo Rodriguez noted that exiting the Brighton, Colorado plant lease significantly improved the company’s capital flexibility by eliminating a $110 million lease liability in exchange for a one-time payment, reinforcing the company's contract manufacturing strategy.[17, 18] Management also projected that gross margins will recover to a 25% target in the second half of 2026 as the high-overhead SiMaxx pilot line in Fremont is fully decommissioned and outsourced volume scales.[11, 26]
The stock price dropped significantly by 24.72% in after-hours trading immediately following the earnings release on May 7, 2026, closing at $16.11 from the pre-announcement price of $21.40, reflecting investor concern over the sequential gross margin contraction and wider-than-expected net loss.[11]
Despite the immediate sell-off, Wall Street analysts remained constructive.[27] Of the nine analysts covering the stock, the consensus rating remained a "Strong Buy" or "Moderate Buy".[27, 32, 33] The consensus 12-month price target consolidated around $19.75 to $22.13, with major investment banks (including B. Riley Financial and Craig-Hallum) raising or reiterating price targets in the $21.00 to $22.00 range, viewing the earnings miss as a temporary operational friction in an otherwise robust growth narrative.[27, 28, 32, 33]
Traditional valuation multiples are currently less meaningful given the company's net losses.[27, 32] Instead, the company's valuation is sensitive to:
* The 5-Year Revenue Growth Profile: Amprius posted a 3-year revenue CAGR of over 200% leading into 2025 ($73.0 million in FY2025 vs. $24.2 million in FY2024) and guides to a 78% expansion in FY2026.[1, 17] Sustaining a 35% to 50% top-line compound annual growth rate over the next five years is the single largest variable for scale valuation.
* Gross Margin Normalization: Connecting valuation to the core business model relies on the company's ability to transition entirely to contract manufacturing.[3] The core economic hypothesis is that outsourced gigawatt-scale production will allow Amprius to maintain premium pricing while significantly lowering unit costs, driving gross margins from the current 20% toward a steady-state 30%+.[1, 24]
* Working Capital and Dilution Management: The company ended Q1 2026 with $62.4 million in cash and no debt [7, 29], but experienced a high quarterly operating cash outflow of $37.3 million due to the one-time $20.0 million Brighton lease exit payment.[5] Although $6.5 million in accounts receivable was subsequently collected in April (bringing cash to $71.2 million as of May 1) [7, 30], cash burn remains high. Proactive dilution control, such as the May 2026 warrant-for-share exchange that retired 7.1 million public warrants in exchange for 2.7 million unregistered shares (estimated to save shareholders $70 million in potential dilution), is a vital valuation driver.[26, 34]
The primary internal risk centers on technology transfer and partner operational performance.[6] Since Amprius utilizes third-party gigawatt-scale lines in South Korea and the United States, any manufacturing yield issues, quality deviations, or communication breakdowns during the transmission of its silicon-anode cell designs would directly impact commercial deliveries and erode gross margins.[3, 4, 20]
Additionally, the ongoing phase-out of the legacy SiMaxx pilot line at the Fremont facility represents an operational transition.[11] Any delays in decommissioning this high-overhead equipment could prolong margin pressure.[11, 26]
Amprius operates at the low-volume, premium-performance end of the energy storage spectrum.[10, 21] If tier-one global battery conglomerates (such as CATL, LG Energy Solution, or Panasonic) successfully optimize silicon-graphite or silicon-dominant anodes on their massive gigawatt-hour lines, they could achieve significant economies of scale and drive down prices.[21] This price compression could undermine Amprius' premium pricing strategy in the light electric vehicle and commercial drone sectors.[21, 35] Furthermore, rapid commercialization breakthroughs by solid-state battery startups could leapfrog the energy density of Amprius’ liquid-electrolyte cells, rendering its platforms obsolete.[21]
The company’s revenue profile is highly concentrated, with three key customers generating 49% of total sales in the first quarter of 2026.[5] This customer concentration makes Amprius vulnerable to the loss of any single major buyer.[6]
Additionally, a significant portion of current demand is tied to defense and high-conflict zones, illustrated by $10.0 million in Q1 2026 sales to Ukraine-based drone applications.[5] This concentration ties corporate performance to volatile geopolitical situations and lumpy military aid funding.[5, 6]
Under the updated U.S. National Defense Authorization Act (NDAA), the Department of Defense is prohibited from purchasing weapons or support systems utilizing battery components made by "foreign entities of concern" (FEOC) such as China or Russia, starting January 1, 2028.[18, 36] Since Amprius has historically utilized manufacturing partnerships in China, it must qualify its domestic supply chain through Nanotech Energy [4, 18] and source NDAA-compliant components for all 11 critical battery materials.[18, 36] Any failures or delays in this compliance pivot would freeze its U.S. military contracts.[36]
Although the company remains debt-free with $62.35 million in cash at the end of Q1 2026, its cash burn rate remains high, with a quarterly operating cash outflow of $37.30 million (impacted by the $20.0 million Brighton lease termination fee).[5, 7, 29] As the company scales its contract manufacturing strategy, working capital demands (including $35.26 million in receivables) could strain cash reserves.[6, 29] If contract operations fail to generate positive cash flow by late 2026/early 2027, the company may be forced to raise capital through highly dilutive equity offerings or high-cost debt in restrictive credit markets.[5, 6]
As a global player sourcing specialized battery components, Amprius is sensitive to tariffs, trade barriers, and export restrictions (particularly graphite, high-grade silicon, and specialized chemical precursors).[6, 29, 37] Macroeconomic headwinds, such as persistent inflation or changes in spending by government agencies and contractors, could impact defense procurement budgets.[37]
Furthermore, high-energy-density cells concentrate thermal and chemical energy, raising safety and thermal runaway risks during certification or flight testing.[9, 10] Any high-profile safety failure or product liability claim would cause severe brand damage.[6, 9]
+-----------------------------------------------------------------------------------------+
| 1. WHAT COULD GO WRONG? |
| - Production delays or yield issues at South Korean or domestic partner facilities. |
| - Failure to source NDAA-compliant precursors for all 11 critical components. |
| - Loss of a major defense customer or sudden termination of Ukraine shipments. |
+-----------------------------------------------------------------------------------------+
|
v
+-----------------------------------------------------------------------------------------+
| 2. EARLY WARNING SIGNS |
| - Gross margins failing to recover to the 25% target in H2 2026. |
| - Delayed qualification milestones with major Chinese LEV and global eVTOL clients. |
| - Elevated cash burn leading to cash reserves falling below $40 million. |
+-----------------------------------------------------------------------------------------+
|
v
+-----------------------------------------------------------------------------------------+
| 3. DAMAGE TO THE LONG-TERM THESIS |
| - A catastrophic thermal runaway safety recall on commercial drone platforms. |
| - Inability to secure NDAA certification by 2028, eliminating U.S. defense business. |
| - Capital-light model failing to achieve unit cost targets, leading to chronic losses.|
+-----------------------------------------------------------------------------------------+
To estimate a realistic valuation range for Amprius over a five-year horizon (FY 2031), three operational scenarios are modeled. This projection utilizes the current share price of $16.03 (as of May 22, 2026) [28] and a current basic share count of 141.6 million shares (reflecting recent post-Q1 warrant exchanges and RSU vesting).[29, 34] The 2026 revenue guidance base is modeled at $130.0 million.[1]
This scenario assumes successful scaling of the SiCore platform through established contract manufacturers in South Korea and the U.S., while the ground-mobility (LEV) and UAS segments experience steady global adoption.
* 5-Year Revenue CAGR: 45% (growing from the 2026 base of $130.0 million to Year 5).
$\text{Year 5 Revenue} = \$130.0\text{M} \times (1.45)^5 = \$833.5\text{ million}$
* Net Margin: 12.0%, reflecting stable operating leverage as Fremont overhead fades and contract manufacturing volumes optimize.
$\text{Year 5 Net Profit} = \$833.5\text{M} \times 0.12 = \$100.0\text{ million}$
* Dilution / Share Count: Assumes gradual share expansion to 160.0 million outstanding shares due to ongoing employee equity compensation and minor expansion-driven capital raises.
* Valuation Multiple: 30x Price-to-Earnings (P/E), reflecting a mature but fast-growing green technology provider.
$\text{Year 5 Market Cap} = \$100.0\text{M} \times 30 = \$3.00\text{ billion}$$\text{Implied Share Price} = \frac{\$3.00\text{B}}{160.0\text{M shares}} = \$18.75$$\text{Total 5-Year Return} = \frac{\$18.75 - \$16.03}{\$16.03} = 17.0\% \quad (\text{Annualized: } 3.2\%)$
This scenario assumes hyper-growth driven by a highly successful commercial takeoff of the eVTOL/air-taxi transport sector, complete NDAA compliance that captures dominant share in U.S. defense programs, and rapid licensing of proprietary SiMaxx technology.
* 5-Year Revenue CAGR: 60%
$\text{Year 5 Revenue} = \$130.0\text{M} \times (1.60)^5 = \$1,363.0\text{ million}$
* Net Margin: 18.0%, driven by premium pricing power on the ultra-dense SiMaxx platform and high-margin licensing streams.
$\text{Year 5 Net Profit} = \$1,363.0\text{M} \times 0.18 = \$245.3\text{ million}$
* Dilution / Share Count: Assumes 170.0 million shares outstanding (wider equity grants for rapid commercial expansion).
* Valuation Multiple: 35x P/E, given premium industry leadership and secular defense/eVTOL tailwinds.
$\text{Year 5 Market Cap} = \$245.3\text{M} \times 35 = \$8.59\text{ billion}$$\text{Implied Share Price} = \frac{\$8.59\text{B}}{170.0\text{M shares}} = \$50.53$$\text{Total 5-Year Return} = \frac{\$50.53 - \$16.03}{\$16.03} = 215.2\% \quad (\text{Annualized: } 25.8\%)$
This scenario assumes execution failure in the contract manufacturing transfer, loss of defense business due to failure to meet the 2028 FEOC sourcing rules, and severe pricing pressure from traditional Asian battery giants.
* 5-Year Revenue CAGR: 15%
$\text{Year 5 Revenue} = \$130.0\text{M} \times (1.15)^5 = \$261.5\text{ million}$
* Net Margin: 3.0%, reflecting persistent overhead, low scale, and pricing concessions.
$\text{Year 5 Net Profit} = \$261.5\text{M} \times 0.03 = \$7.8\text{ million}$
* Dilution / Share Count: Assumes heavy dilution to 180.0 million shares to continually fund operating losses.
* Valuation Multiple: 1.5x Price-to-Sales (P/S) multiple, as the company is valued on low-growth distressed sales rather than earnings.
$\text{Year 5 Market Cap} = \$261.5\text{M} \times 1.5 = \$392.3\text{ million}$$\text{Implied Share Price} = \frac{\$392.3\text{M}}{180.0\text{M shares}} = \$2.18$$\text{Total 5-Year Return} = \frac{\$2.18 - \$16.03}{\$16.03} = -86.4\% \quad (\text{Annualized: } -33.0\%)$
The modeled trajectories indicate highly divergent paths over the next five years, emphasizing the importance of operational scale-up milestones and execution under the capital-light contract manufacturing strategy:
| Scenario | Year 0 (Current) | Year 1 (FY2027) | Year 2 (FY2028) | Year 3 (FY2029) | Year 4 (FY2030) | Year 5 (FY2031) |
|---|---|---|---|---|---|---|
| High Case | $16.03 | $20.00 | $25.50 | $32.50 | $41.00 | $50.53 |
| Base Case | $16.03 | $16.50 | $17.00 | $17.50 | $18.00 | $18.75 |
| Low Case | $16.03 | $11.50 | $8.00 | $5.50 | $3.50 | $2.18 |
Using the subjective probability weights, the mathematically calculated probability-weighted target price is:
$\text{Expected Share Price (5-Year Target)} = (0.50 \times \$18.75) + (0.25 \times \$50.53) + (0.25 \times \$2.18) = \$9.38 + \$12.63 + \$0.55 = \$22.56$
This expected share price target of $22.56 implies an estimated total return of 40.7% over five years, corresponding to an annualized return of 7.1%.
| Scenario | Revenue / key scale metric in Year 5 | Margin / earnings assumption | Valuation multiple assumption | Current share price | Implied future share price | 5-year total return | Annualized return | Probability |
|---|---|---|---|---|---|---|---|---|
| High Case | $1,363.0M Revenue [1] | 18.0% Net Margin / $245.3M Net Income | 35.0x P/E | $16.03 [28] | $50.53 | 215.2% | 25.8% | 25.0% |
| Base Case | $833.5M Revenue [1] | 12.0% Net Margin / $100.0M Net Income | 30.0x P/E | $16.03 [28] | $18.75 | 17.0% | 3.2% | 50.0% |
| Low Case | $261.5M Revenue [1] | 3.0% Net Margin / $7.8M Net Income | 1.5x P/S [38] | $16.03 [28] | $2.18 | -86.4% | -33.0% | 25.0% |
SCALE-UP IS KEY
HIGH-CONVIRTION GROWTH IN PLAY
Amprius Technologies Inc presents a high-growth, high-conviction technology thesis centered on a transition from a low-volume pilot manufacturer to a capital-light, high-volume energy storage provider.[3, 4] The company’s core technology is structurally superior, validated by leading military and aerospace prime contractors who depend on its energy density lead to enable critical flight hardware.[13, 21]
In summary, the fundamental analysis suggests that if Amprius can successfully commercialize its asset-light manufacturing pivot while defending its technical energy-density moat, the current risk-reward profile is highly favorable for growth-oriented portfolios.
PROVE THE SCALE
Amprius' recent price action has shown a strong constructive recovery, with the stock closing at $16.03 on May 22, 2026.[28, 43] Depending on the calculation methodology, the company's unadjusted 200-day Simple Moving Average (SMA) stands at $18.84, indicating a long-term technical ceiling, while splits and daily-adjusted SMA models indicate primary technical support at $12.65.[44, 45]
While the stock suffered a sharp 24.72% drop immediately following the Q1 EPS and margin miss, technical buyers have consistently defended support in the $14.25 to $15.50 range, demonstrating constructive demand.[11, 28, 43] In the short term, technical indicators point to near-term consolidation between $14.50 and $18.50 as the market digests the legacy SiMaxx phase-out and monitors the South Korean manufacturing ramp-up.[11, 44]
CONSOLIDATION AND BASE-BUILDING
View Amprius Technologies, Inc. (AMPX) stock page
Loading the interactive version of this report…